How omega-3 fatty acids support brain health

May 06, 2021 by Joel Fuhrman, MD


The omega-3 fatty acids DHA and EPA are crucial for brain health through all stages of life

One of the foundational principles of the Nutritarian diet is to limit or avoid animal products. Many people know that they need omega-3 fatty acids in their diet, so they eat fish as their primary source of these nutrients. But while a small amount of wild-caught fish (less than 6 oz. per week) may be acceptable, it is still not a favorable source of EPA and DHA. That’s because fish may provide pollutants and other serious drawbacks:

  • The excess animal protein can raise IGF-1 levels, into a harmful range.1
  • Microplastic particles from the dumping of plastic garbage into our oceans and waterways.
  • Fish often contains high levels of other pollutants such as methylmercury and PCBs.3 

Related: How Plant Protein Wins Over Animal Protein

My opinion is that the benefits of eating fish do not outweigh the risks—especially when you can use a clean algae-based omega-3 supplement. Additionally, an algae-derived DHA and EPA, such as my DHA+EPA Purity, is a more sustainable option, and it is free of the environmental pollutants that accumulate in the fatty tissues of fish. If you do eat fish, I recommend limiting your consumption to 6 ounces per week, and sticking with varieties that are lowest in mercury, such as trout, flounder, oysters, sardines, shrimp, pollock and wild salmon.4

Sources:

Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence
Microplastic Contamination of Seafood Intended for Human Consumption: A Systematic Review and Meta-Analysis
Environmental Working Group. PCBs in Farmed Salmon 
EPA-FDA Advisory on Mercury in Fish and Shellfish

Can I meet my omega-3 needs with nuts and seeds? 

Conversion of ALA (from walnuts, flax seeds and chia seeds) varies between individuals, is overall inefficient, and is most often insufficient to provide optimal DHA levels.5 A study measuring blood DHA and EPA in a vegan population found that 64 percent were insufficient and some were very severely deficient. Those insufficiencies were not related to ALA intake (which was far above recommended intake), suggesting that genetic or other inherent differences in conversion enzyme activity determines DHA and EPA levels more than ALA intake.  Also in this study, a moderate dose of algae-derived DHA and EPA (254 mg/day) was able to normalize the levels when rechecked four months later.6 This research confirms that high ALA intake in many cases is not enough to assure DHA and EPA adequacy, and suggests that omega-3 supplementation is a useful adjunct to a healthful diet.

Sources:

Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications
Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement

How do omega-3s benefit brain health?

The long-chain omega-3 fatty acids DHA and EPA contribute to many aspects of brain health,7 but most modern diets are low in DHA and EPA, and research has confirmed that vegans tend to have a low omega-3 index.6 DHA is concentrated in the membranes of brain cells; there, DHA provides structure to the membrane and is involved in signaling, connectivity between cells, and neurotransmitter production, among other important actions. EPA and DHA have some common functions and some distinctive ones. DHA is most often associated with brain development, learning and cognition, and EPA with mood and behavior, and anti-inflammatory effects.8-11 

Omega-3 fatty acid adequacy is associated with lower risk of premature death, according to a meta-analysis of 17 studies that investigated blood omega-3 levels and death from all causes. Participants in the highest fifth of combined blood DHA and EPA were 15-18% less likely to die over the follow-up periods of these studies, a median of 16 years. Similar associations were found for death from cardiovascular disease and cancer. In addition to their crucial role in the brain, DHA and EPA have triglyceride-lowering, anti-inflammatory, anti-platelet, and anti-hypertensive properties, plus effects on cell membranes that may also contribute to promoting longevity.12

Sources:

The Importance of Marine Omega-3s for Brain Development and the Prevention and Treatment of Behavior, Mood, and Other Brain Disorders
Diet and cognition: interplay between cell metabolism and neuronal plasticity
Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA

Pre-natal and babies: Early brain development

DHA and EPA are building blocks of human brain and retina tissue, and sufficient omega-3 levels  are important for early neurodevelopment and throughout life for vision and brain function.7,8,13  Maternal stores provide the developing baby with the DHA for brain and eye development, and after birth, the DHA is provided by breast milk.   

Sources:

The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: a review
Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials

Children and teens: Learning, attention and behavior

Although the time between birth and 2 years represents the phase of the brain’s largest growth, brain development is not complete after age 2; it continues through childhood and into the late twenties.8,14  Omega-3 supplementation trials in children have reported improvements in measures of school performance (such as reading, spelling or learning ability) or behavior.

One interesting study used functional MRI to view activity in the brains of young boys (8-10 years of age) who took either placebo or a DHA supplement for 8 weeks. The boys who took DHA showed increased functional brain activity during a cognitive task, and their level of activation correlated directly with their blood DHA levels.15 This study suggests that DHA in the brain is involved in the learning process in children. 

This research has significant implications, since early academic success helps to build confidence and set the stage for future college and career performance. Another study on teens (age 13-15) in the Netherlands found that higher blood omega-3 levels correlated with better scores on cognitive tests.16 

Insufficient DHA levels have been implicated in a number of childhood cognitive and developmental disorders such as ADHD, dyslexia, and autism spectrum disorders.17,18  Supplementation with omega-3s, especially in combination with certain omega-6 fatty acids, has been found to improve symptoms in children with ADHD.19-23 Not enough research has been done on autism spectrum disorders to determine whether omega-3 supplementation would also be helpful for these children.24,25 

Sources:

Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study
Association between Blood Omega-3 Index and Cognition in Typically Developing Dutch Adolescents
Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children
Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids
Omega-3 Fatty Acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis
Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic review

Adults: Improvements in depression symptoms, learning ability

DHA and EPA supplementation showed improvements in depression symptoms and learning ability in adulthood. At this stage of life, omega-3 adequacy helps to maintain optimal brain function, prevent depression, and lay the groundwork for a healthy brain later in life. A 6-month study of DHA and EPA supplementation in young adults (18-45 years of age) documented improvements in measures of memory.26 Additionally, 12 weeks of DHA supplementation was found to improve blood flow to the brains of healthy young adults during a cognitive task.27 

For women, it is important to note that depletion of DHA stores during pregnancy is thought to be responsible for many cases of postpartum depression.28 Pregnancy and nursing is an important time to maintain adequate DHA not only for the baby, but for the mother too.

Long-chain omega-3 fatty acids can affect the metabolism of mood-related neurotransmitters such as serotonin and dopamine; in addition, the anti-inflammatory effects of DHA and EPA are thought to contribute to reducing depression symptoms.  Higher fish consumption or omega-3 intake is linked to a lower risk of depression.22,29-31  Omega-3 supplements have also been extensively studied as a treatment for depression.  EPA is primarily responsible for the anti-depressant effects of omega-3 supplements, according to a multiple meta-analyses of trials investigating omega-3 supplements for depression.32-35 

Sources:

DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial
DHA-rich oil modulates the cerebral haemodynamic response to cognitive tasks in healthy young adults: a near IR spectroscopy pilot study
Role of docosahexaenoic acid in maternal and child mental health
Omega-3 fatty acids and depression: scientific evidence and biological mechanisms
EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials
Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder

Older adults: Preserving memory, preventing diseases

Maintaining adequate levels of DHA and EPA helps to preserve memory and other cognitive functions  in older age. Omega-3 fatty acids appear to be useful for preventing Alzheimer’s disease and Parkinson’s disease, the two most common neurodegenerative diseases. Low omega-3 intake and low levels of DHA in the blood are associated with age-related cognitive decline and Alzheimer’s disease.36-38  Also, low blood DHA levels are linked to cognitive impairment and Alzheimer’s disease, and DHA depletion in certain areas of the brain occurs in Alzheimer’s disease.37,39  In some studies, low plasma EPA also associated with risk of dementia or cognitive decline.11 

Other studies have investigated brain volume and structural changes, finding that higher blood omega-3 levels are associated with larger brain volumes and reduced dementia-related changes in older people, implying that sufficient DHA and EPA could help to prevent brain shrinkage with age.40-42  

Beginning supplementation once memory problems have become apparent may have limited utility compared to maintaining adequate levels throughout life. For preventing cognitive decline in older adults, the supplementation trials have shown that healthy older people, or those with mild cognitive impairment or mild memory complaints may benefit from omega-3 supplementation, whereas those with established Alzheimer’s disease likely do not.36,37,43-46

For example, one study in adults with mild age-related cognitive decline compared DHA and placebo, taken for six months, and administered learning and memory tests before and after. In this study, the DHA group improved their learning and memory scores.47  A similar study that tested the effects of DHA on subjects who had already been diagnosed with Alzheimer’s disease did not find any cognitive improvements.48  This research implies that maintaining sufficient omega-3 levels throughout life is an effective preventive measure.

It is known that DHA levels are low in the brains of Parkinson’s patients. Similarly, in my clinical experience, I have seen a number of elderly, male vegans who developed Parkinson’s disease; these men were severely deficient in DHA. DHA-EPA deficiency has been shown to sensitize the brain to the chemicals that play a role in Parkinson’s disease in primate studies and other animal studies. Alzheimer’s disease and Parkinson’s disease share the underlying causes of oxidative stress, inflammation and mitochondrial dysfunction. DHA and EPA may offer protection by producing anti-inflammatory mediators in the brain.11,49

Sources:

Blood fatty acids in Alzheimer's disease and mild cognitive impairment: A meta-analysis and systematic review
Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study
Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging
Long-chain omega-3 polyunsaturated fatty acids and cognitive decline in non-demented adults: a systematic review and meta-analysis
Effectiveness of omega-3 fatty acid supplementation in patients with Alzheimer disease: A systematic review and meta-analysis
Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials
Docosahexaenoic acid and adult memory: a systematic review and meta-analysis
The emerging role of nutrition in Parkinson's disease
 

The takeaway: Protect yourself now

No matter what your age, maintaining adequate omega-3 stores is crucial now and for the later life health and functionality of your brain. A Nutritarian diet provides many nutrients that benefit brain health but to assure our DHA-EPA intake is optimized we should maintain an omega-3 index greater than 5, because lower levels are increasingly associated with cognitive impairment and brain shrinkage.    

It just makes good sense to either test your blood for omega-3 fatty acid levels to assure that you are sufficient, or take a supplement, or both.  
 

 
References
  1. Kaaks R. Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp 2004, 262:247-260; discussion 260-268. doi:
  2. Danopoulos E, Jenner LC, Twiddy M, Rotchell JM. Microplastic Contamination of Seafood Intended for Human Consumption: A Systematic Review and Meta-Analysis. Environ Health Perspect 2020, 128:126002. doi: 10.1289/EHP7171
  3. Environmental Working Group. PCBs in Farmed Salmon. [http://www.ewg.org/research/pcbs-farmed-salmon ]
  4. EPA-FDA Advisory on Mercury in Fish and Shellfish [https://www.epa.gov/fish-tech/epa-fda-advisory-mercury-fish-and-shellfish]
  5. Davis BC, Kris-Etherton PM. Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. American Journal of Clinical Nutrition 2003, 78:640S-646S. doi:
  6. Sarter B, Kelsey KS, Schwartz TA, Harris WS. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement. Clin Nutr 2014. doi: 10.1016/j.clnu.2014.03.003
  7. DiNicolantonio JJ, O'Keefe JH. The Importance of Marine Omega-3s for Brain Development and the Prevention and Treatment of Behavior, Mood, and Other Brain Disorders. Nutrients 2020, 12. doi: 10.3390/nu12082333
  8. Kuratko CN, Barrett EC, Nelson EB, Salem N, Jr. The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: a review. Nutrients 2013, 5:2777-2810. doi: 10.3390/nu5072777
  9. Stonehouse W. Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials. Nutrients 2014, 6:2730-2758. doi: 10.3390/nu6072730
  10. Gomez-Pinilla F, Tyagi E. Diet and cognition: interplay between cell metabolism and neuronal plasticity. Curr Opin Clin Nutr Metab Care 2013, 16:726-733. doi: 10.1097/MCO.0b013e328365aae3
  11. Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci 2015, 7:52. doi: 10.3389/fnagi.2015.00052
  12. Harris WS, Tintle NL, Imamura F, et al. Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies. Nature Communications 2021, 12:2329. doi: 10.1038/s41467-021-22370-2
  13. Higdon J: Essential Fatty Acids. In An Evidence-Based Approach to Dietary Phytochemicals. New York, NY: Thieme; 2006: 78-99
  14. Bowman GL, Silbert LC, Howieson D, et al. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2011. doi: 10.1212/WNL.0b013e3182436598
  15. McNamara RK, Able J, Jandacek R, et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr 2010, 91:1060-1067. doi: 10.3945/ajcn.2009.28549
  16. van der Wurff IS, von Schacky C, Berge K, et al. Association between Blood Omega-3 Index and Cognition in Typically Developing Dutch Adolescents. Nutrients 2016, 8. doi: 10.3390/nu8010013
  17. Schuchardt JP, Huss M, Stauss-Grabo M, Hahn A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. European Journal of Pediatrics 2010, 169:149-164. doi: 10.1007/s00431-009-1035-8
  18. Stevens LJ, Zentall SS, Deck JL, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. American Journal of Clinical Nutrition 1995, 62:761-768. doi:
  19. Sinn N, Bryan J, Wilson C. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial. Prostaglandins Leukotrienes and Essential Fatty Acids 2008, 78:311-326. doi: S0952-3278(08)00050-1 [pii]10.1016/j.plefa.2008.04.004
  20. Sinn N, Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. Journal of Developmental and Behavioral Pediatrics 2007, 28:82-91. doi: 10.1097/01.DBP.0000267558.88457.a500004703-200704000-00002 [pii]
  21. Transler C, Eilander A, Mitchell S, van de Meer N. The impact of polyunsaturated fatty acids in reducing child attention deficit and hyperactivity disorders. J Atten Disord 2010, 14:232-246. doi: 1087054709347250 [pii]10.1177/1087054709347250
  22. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev 2007, 12:207-227. doi:
  23. Bloch MH, Qawasmi A. Omega-3 Fatty Acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry 2011, 50:991-1000. doi: 10.1016/j.jaac.2011.06.008
  24. De Crescenzo F, D'Alo GL, Morgano GP, et al. Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic review. Health Qual Life Outcomes 2020, 18:28. doi: 10.1186/s12955-020-01284-5
  25. James S, Montgomery P, Williams K. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2011:CD007992. doi: 10.1002/14651858.CD007992.pub2
  26. Stonehouse W, Conlon CA, Podd J, et al. DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. Am J Clin Nutr 2013, 97:1134-1143. doi: 10.3945/ajcn.112.053371
  27. Jackson PA, Reay JL, Scholey AB, Kennedy DO. DHA-rich oil modulates the cerebral haemodynamic response to cognitive tasks in healthy young adults: a near IR spectroscopy pilot study. Br J Nutr 2012, 107:1093-1098. doi: 10.1017/S0007114511004041
  28. Ramakrishnan U, Imhoff-Kunsch B, DiGirolamo AM. Role of docosahexaenoic acid in maternal and child mental health. American Journal of Clinical Nutrition 2009, 89:958S-962S. doi: ajcn.2008.26692F [pii]10.3945/ajcn.2008.26692F
  29. Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J 2015, 29:2207-2222. doi: 10.1096/fj.14-268342
  30. Stahl LA, Begg DP, Weisinger RS, Sinclair AJ. The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs 2008, 9:57-64. doi:
  31. Grosso G, Galvano F, Marventano S, et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid Med Cell Longev 2014, 2014:313570. doi: 10.1155/2014/313570
  32. Grosso G, Pajak A, Marventano S, et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 2014, 9:e96905. doi: 10.1371/journal.pone.0096905
  33. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 2009, 28:525-542. doi: 28/5/525 [pii]
  34. Sublette ME, Ellis SP, Geant AL, Mann JJ. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011, 72:1577-1584. doi: 10.4088/JCP.10m06634
  35. Mocking RJ, Harmsen I, Assies J, et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry 2016, 6:e756. doi: 10.1038/tp.2016.29
  36. Cederholm T. Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults - any news? Curr Opin Clin Nutr Metab Care 2017, 20:104-109. doi: 10.1097/MCO.0000000000000350
  37. Cederholm T, Salem N, Jr., Palmblad J. Omega-3 fatty acids in the prevention of cognitive decline in humans. Adv Nutr 2013, 4:672-676. doi: 10.3945/an.113.004556
  38. Yurko-Mauro K. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Curr Alzheimer Res 2010, 7:190-196. doi: CAR -64 [pii]
  39. Hosseini M, Poljak A, Braidy N, et al. Blood fatty acids in Alzheimer's disease and mild cognitive impairment: A meta-analysis and systematic review. Ageing Res Rev 2020, 60:101043. doi: 10.1016/j.arr.2020.101043
  40. Pottala JV, Yaffe K, Robinson JG, et al. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology 2014, 82:435-442. doi: 10.1212/WNL.0000000000000080
  41. Tan ZS, Harris WS, Beiser AS, et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 2012, 78:658-664. doi: 10.1212/WNL.0b013e318249f6a9
  42. Bowman GL, Dodge HH, Mattek N, et al. Plasma omega-3 PUFA and white matter mediated executive decline in older adults. Front Aging Neurosci 2013, 5:92. doi: 10.3389/fnagi.2013.00092
  43. Alex A, Abbott KA, McEvoy M, et al. Long-chain omega-3 polyunsaturated fatty acids and cognitive decline in non-demented adults: a systematic review and meta-analysis. Nutr Rev 2020, 78:563-578. doi: 10.1093/nutrit/nuz073
  44. Araya-Quintanilla F, Gutierrez-Espinoza H, Sanchez-Montoya U, et al. Effectiveness of omega-3 fatty acid supplementation in patients with Alzheimer disease: A systematic review and meta-analysis. Neurologia 2020, 35:105-114. doi: 10.1016/j.nrl.2017.07.009
  45. Zhang XW, Hou WS, Li M, Tang ZY. Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials. Aging Clin Exp Res 2016, 28:165-166. doi: 10.1007/s40520-015-0381-9
  46. Yurko-Mauro K, Alexander DD, Van Elswyk ME. Docosahexaenoic acid and adult memory: a systematic review and meta-analysis. PLoS One 2015, 10:e0120391. doi: 10.1371/journal.pone.0120391
  47. Yurko-Mauro K, McCarthy D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010. doi: S1552-5260(10)00040-3 [pii]10.1016/j.jalz.2010.01.013
  48. Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010, 304:1903-1911. doi: 304/17/1903 [pii]10.1001/jama.2010.1510
  49. Seidl SE, Santiago JA, Bilyk H, Potashkin JA. The emerging role of nutrition in Parkinson's disease. Front Aging Neurosci 2014, 6:36. doi: 10.3389/fnagi.2014.00036

Joel Fuhrman, M.D. is a board-certified family physician, seven-time New York Times bestselling author and internationally recognized expert on nutrition and natural healing, who specializes in preventing and reversing disease through nutritional methods. Dr. Fuhrman coined the term “Nutritarian” to describe his longevity-promoting, nutrient dense, plant-rich eating style.
 
For over 25 years, Dr. Fuhrman has shown that it is possible to achieve sustainable weight loss and reverse heart disease, diabetes and many other illnesses using smart nutrition. In his medical practice, and through his books and PBS television specials, he continues to bring this life-saving message to hundreds of thousands of people around the world.

 

Comments (0):

 View

EatingforLife

05/29/2021 12:45 PM

I feel like testing for Omega 3 index is a fairly new suggestion. I'm grateful to see this, and use the results to potentially tweak doseage. Thanks.

feistyfilly

08/07/2021 11:18 AM

I started taking this several months ago and noticed a change in my memory approximately one month later!!!   Having eaten candy as my meals throughout my life; I am concerned about getting Dementia. I'm vegan, but, that doesn't mean I ate healthily.  This needs to be taken with a healthy fat to be absorbed; such as a few nuts. I recommend this to everyone I can. 

This comment was last edited on 08/07/2021 11:23 AM

davidson02

09/13/2021 06:27 AM

Very informative. It's nice to know the importance of omega 3 in our healthy lifestyle.